menu
    • menu

    Company profile for Ocuphire Pharma

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire’s pipeline currently includes two small-molecule product candidates targeting front and back of the eye indications. Our lead product candidate, Nyxol® Eye Drops, is a once-daily preservative-free eye drop formulation of phentolamine mesylate, a non-selective ...
    We are a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire’s pipeline currently includes two small-molecule product candidates targeting front and back of the eye indications. Our lead product candidate, Nyxol® Eye Drops, is a once-daily preservative-free eye drop formulation of phentolamine mesylate, a non-selective alpha-1 and alpha-2 adrenergic antagonist designed to reduce pupil size and improve visual acuity, and is being developed for several indications, including dim light or night vision disturbances.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ocuphire PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    37000 Grand River Ave, Suite 120 Farmington Hills, MI 48335
    Telephone
    Telephone
    (248) 681-9815
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ocuphire.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ocuphire-pharma
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Shareholder Group Nominates Majority Slate to Opus Genetics Board
    Shareholder Group Nominates Majority Slate to Opus Genetics Board

    07 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/07/3022822/0/en/Shareholder-Group-Led-by-Founder-Mina-Sooch-Nominates-Majority-Slate-of-Director-Candidates-to-the-Board-of-Opus-Genetics-Inc.html

    GLOBENEWSWIRE
    07 Feb 2025
    Share Share
    Opus Genetics Announces Financial Results for Q3 2024 & Update
    Opus Genetics Announces Financial Results for Q3 2024 & Update

    12 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/12/2979129/0/en/Opus-Genetics-Announces-Financial-Results-for-Third-Quarter-2024-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    12 Nov 2024
    Share Share
    Ocuphire to transform into gene therapy biotech via Opus buyout
    Ocuphire to transform into gene therapy biotech via Opus buyout

    23 Oct 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/ocuphire-transform-gene-therapy-focused-biotech-opus-acquisition

    FIERCE BIOTECH
    23 Oct 2024
    Share Share
    Ocuphire Pharma Announces Acquisition of Opus Genetics
    Ocuphire Pharma Announces Acquisition of Opus Genetics

    22 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/22/2967317/0/en/Ocuphire-Pharma-Announces-Acquisition-of-Opus-Genetics.html

    GLOBENEWSWIRE
    22 Oct 2024
    Share Share
    Ocuphire Publishes Ph 3 Results For RYZUMVI Ophthalmic Solution
    Ocuphire Publishes Ph 3 Results For RYZUMVI Ophthalmic Solution

    30 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/en/news-release/2024/09/30/2955118/0/en/Ocuphire-Pharma-Announces-Publication-of-Full-Phase-3-Results-of-Phentolamine-Ophthalmic-Solution-0-75-for-Pharmacologically-Induced-Mydriasis-in-Ophthalmology.html

    GLOBENEWSWIRE
    30 Sep 2024
    Share Share
    Ocuphire Initiates Ph 3 Trial of Phentolamine for Presbyopia
    Ocuphire Initiates Ph 3 Trial of Phentolamine for Presbyopia

    05 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/06/2941917/0/en/UPDATE-Ocuphire-Pharma-Initiates-VEGA-3-Phase-3-Trial-Evaluating-Phentolamine-Ophthalmic-Solution-0-75-for-Presbyopia.html

    GLOBENEWSWIRE
    05 Sep 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search